| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 249.636.673 $ | +84.472.186 $ | +76,7 % | 11 | 129.115.877 $ | +25.600.010 $ | +48,6 % | 7 | 134.541.502 $ | +68.305.915 $ | +56,5 % | 7 | ||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Neutral | 36.299.814 $ | +20.005.495 $ | +122,8 % | 1 | 16.294.319 $ | +7.955.332 $ | +95,4 % | 1 | ||||
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Neutral | 34.245.687 $ | -819.528 $ | -2,3 % | 1 | 35.065.215 $ | +4.623.310 $ | +15,2 % | 1 | 30.441.905 $ | +3.274.113 $ | +12,1 % | 1 |
| TOWER SEMICONDUCTOR LTD | TSEM | → 0 | Sehr stark | 25.573.578 $ | +11.188.102 $ | +77,8 % | 1 | 14.385.476 $ | -8.157.809 $ | -36,2 % | 1 | 22.543.285 $ | +11.067.586 $ | +96,4 % | 1 |
| FINANCIAL COUNSELORS INC | → 0 | 25.546.001 $ | +17.010.901 $ | +199,3 % | 1 | ||||||||||
| NOVA LTD. | NVMI | → 0 | Neutral | 23.175.786 $ | +7.463.638 $ | +47,5 % | 1 | 15.712.148 $ | +1.680.353 $ | +12,0 % | 1 | 14.031.795 $ | -6.838.272 $ | -32,8 % | 1 |
| NICE Ltd. | NICE | → 0 | Neutral | 22.788.372 $ | +22.788.372 $ | 1 | |||||||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 19.714.802 $ | +13.887.104 $ | +238,3 % | 1 | ||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Sehr schwach | 18.211.968 $ | +9.970.476 $ | +121,0 % | 1 | ||||||||
| BIOGEN INC. | BIIB | → 0 | Neutral | 16.962.792 $ | +289.851 $ | +1,7 % | 1 | 16.672.941 $ | +5.083.002 $ | +43,9 % | 1 | ||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 16.955.526 $ | +1.991.197 $ | +13,3 % | 1 | 14.964.329 $ | +4.359.384 $ | +41,1 % | 1 | ||||
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Neutral | 16.925.792 $ | +904.343 $ | +5,6 % | 1 | 16.021.449 $ | +10.056.438 $ | +168,6 % | 1 | ||||
| Cidara Therapeutics, Inc. | → 0 | 16.829.150 $ | +10.107.121 $ | +150,4 % | 1 | ||||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 16.024.927 $ | +2.580.607 $ | +19,2 % | 1 | ||||||||
| Merus N.V. | → 0 | 14.122.500 $ | +14.122.500 $ | 1 | |||||||||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 13.784.495 $ | +13.784.495 $ | 1 | ||||||||||
| 249.636.673 $ | +84.472.186 $ | +76,7 % | 11 | 129.115.877 $ | +25.600.010 $ | +48,6 % | 7 | 134.541.502 $ | +68.305.915 $ | +56,5 % | 7 | ||||